BLCOライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (4 5月 2024 @ 05:00):

Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical...

Stats
本日の出来高	523 318
平均出来高	499 950
時価総額	4.77B
EPS	$0.240 ( 2024-05-01 )
次の収益日	( $0 ) 2024-07-31
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-14.17
ATR14	$0.0140 (0.10%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-24	Stewart Andrew J.	Sell	3 943	Common Shares, No Par Value
2024-04-24	Bailey A Robert D	Sell	9 838	Common Shares, No Par Value
2024-03-29	Robertson Russel C	Buy	1 481	Common Shares, No Par Value
2024-03-29	Paulson John	Buy	1 264	Common Shares, No Par Value
2024-03-29	De Schutter Richard U	Buy	1 553	Common Shares, No Par Value

INSIDER POWER
-8.30
Last 94 transactions
Buy: 2 803 512 \| Sell: 8 839 600

ボリューム相関

長: -0.57 (weak negative)

短: 0.59 (weak)

Signal:(42.754) Neutral

Bausch + Lomb Corporation 相関

10 最も正の相関
BPMP	0.903
ARC	0.848
BMA	0.847
TPR	0.84
HSBC	0.834
BIP-PA	0.83
CMCM	0.829
BFS-PD	0.826
SUPV	0.818
ANF	0.818

10 最も負の相関
EPV	-0.803

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Bausch + Lomb Corporation 相関 - 通貨/商品

-0.57
( weak negative )

-0.35
( neutral )

0.00
( neutral )

-0.46
( neutral )

0.69
( moderate )

Bausch + Lomb Corporation 財務諸表

Annual	2023
収益:	$4.15B
総利益:	$2.50B (60.40 %)
EPS:	$-0.740

FY	2023
収益:	$4.15B
総利益:	$2.50B (60.40 %)
EPS:	$-0.740

FY	2022
収益:	$3.77B
総利益:	$2.25B (59.69 %)
EPS:	$0.0429

FY	2021
収益:	$3.77B
総利益:	$2.30B (61.04 %)
EPS:	$0.520

Financial Reports:

No articles found.

Bausch + Lomb Corporation

Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, and dry eye. The Ophthalmic Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of eye conditions, such as glaucoma, ocular hypertension, and retinal diseases; and contact lenses for therapeutic use. The Surgical segment provides tools and technologies for the treatment of cataracts, and vitreous and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices. The company was founded in 1853 and is headquartered in Vaughan, Canada.